Author: Javier Fernandez-Diaz

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Given the good track record of the stock market as an alternative source of financing, the biotechnology company Laminar Pharma is taking its first steps to attract private investors and institutions, by joining...

La biotecnológica balear Laminar Pharmaceuticals se acerca al Mercado Alternativo Bursátil       ...

La hidroxilación de moléculas lipídicas podría ser una buena estrategia para tratar el Alzheimer       ...